Dynamic Visual Display of Treatment Response in HIV-Infected Adults

被引:2
|
作者
Edwards, Jessie K. [1 ]
Cole, Stephen R. [1 ]
Martin, Jeffrey N. [2 ]
Moore, Richard [3 ]
Mathews, W. Christopher [4 ]
Kitahata, Mari [5 ]
Eron, Joseph J. [6 ]
Saag, Michael [7 ]
Mugavero, Michael J. [7 ]
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA
[7] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
HIV/AIDS; antiretroviral therapy; NONPARAMETRIC-ESTIMATION;
D O I
10.1093/cid/civ262
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Using a dynamic visual display, we examine the changes in human immunodeficiency virus type 1 ( HIV-1) plasma viral load and CD4 cell count for 5 years after antiretroviral therapy initiation in a large cohort of patients with HIV. Methods. Patients at a Centers for AIDS Research Network of Integrated Clinical Systems site who initiated combination antiretroviral therapy between 1 January 2000 and 31 December 2012 were followed for 5 years for HIV-1 plasma viral load, CD4 cell count, and mortality. The joint distribution of CD4 cell count and viral load over time was depicted in an animated display using a bivariate kernel smoother. Results. Within days of therapy initiation, many patients had a suppressed viral load and their median CD4 cell count had increased. However, the median CD4 cell count remained below normal levels throughout follow-up period and the proportion of patients with high viral load occasionally increased, even years after therapy initiation. Conclusions. The dramatic changes in viral load and CD4 cell count after therapy initiation highlight the over-whelming effectiveness of antiretroviral therapy in the modern era. However, this work also emphasizes the need for pharmaceutical or behavioral interventions to prevent virologic failure and to stimulate complete recovery of normal CD4 cell count.
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 50 条
  • [21] Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults
    Gbabe, Oluwatoyin F.
    Okwundu, Charles I.
    Dedicoat, Martin
    Freeman, Esther E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [22] Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults
    Wilson, D
    Nachega, J
    Morroni, C
    Chaisson, R
    Maartens, G
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (01) : 31 - 38
  • [23] Vaccinating HIV-infected children - response
    Arpadi, SM
    INFECTIONS IN MEDICINE, 1998, 15 (03) : 198 - 198
  • [24] Eosinophilia in HIV-Infected Cases Response
    Al Mohajer, Mayar
    Villarreal-Williams, Erick
    Andrade, Roberto A.
    Giordano, Thomas P.
    Serpa, Jose A.
    SOUTHERN MEDICAL JOURNAL, 2014, 107 (12) : 788 - 788
  • [25] Pattern- and motion-related visual evoked potentials in HIV-infected adults
    Szanyi, Jana
    Kremlacek, Jan
    Kubova, Zuzana
    Kuba, Miroslav
    Gebousky, Pavel
    Kapla, Jaroslav
    Szanyi, Juraj
    Vit, Frantisek
    Langrova, Jana
    DOCUMENTA OPHTHALMOLOGICA, 2017, 134 (01) : 45 - 55
  • [26] Pattern- and motion-related visual evoked potentials in HIV-infected adults
    Jana Szanyi
    Jan Kremlacek
    Zuzana Kubova
    Miroslav Kuba
    Pavel Gebousky
    Jaroslav Kapla
    Juraj Szanyi
    Frantisek Vit
    Jana Langrova
    Documenta Ophthalmologica, 2017, 134 : 45 - 55
  • [27] Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda
    Seremba, E.
    Ocama, P.
    Ssekitoleko, R.
    Mayanja-Kizza, H.
    Adams, S., V
    Orem, J.
    Katabira, E.
    Reynolds, S. J.
    Nabatanzi, R.
    Casper, C.
    Phipps, W.
    VACCINE, 2021, 39 (08) : 1265 - 1271
  • [28] Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore
    Lau, Yuk-Fai
    Tang, Lay-Hoon
    Lye, David Chien
    Ooi, Eng-Eong
    Leo, Yee-Sin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 551 - 560
  • [29] CATS AND TOXOPLASMOSIS RISK IN HIV-INFECTED ADULTS
    WALLACE, MR
    ROSSETTI, RJ
    OLSON, PE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (01): : 76 - 77
  • [30] Pneumococcal conjugate vaccine for HIV-infected adults
    Naus, Monika
    BRITISH COLUMBIA MEDICAL JOURNAL, 2015, 57 (02): : 62 - 62